Metastatic carcinoma of the male breast treated with bilateral adrenalectomy and chemotherapy
β Scribed by Min C. Li; Donald E. Janelli; Edward J. Kelly; Himeko Kashiwabara; Re Hwe Kim
- Publisher
- John Wiley and Sons
- Year
- 1970
- Tongue
- English
- Weight
- 342 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. The objective of the current study was to analyze the impact of adjuvant chemotherapy in comparison with other prognostic parameters on the outcome of a series of patients with breast carcinoma at time of metastatic recurrence. ## METHODS. Data from 1430 patients accrued in 8 pro
## Results . Forty-eight (23%) of the 207 specimens demonstrated high STn staining ter, Houston, Texas. (ΓΊ25% cells were immunoreactive). During a median follow-up of 5 years, high STn patients had worse disease free survival than low STn patients (55% vs. 74%,
The data presented were obtained in partial fulfillment of the requirements for the degree of Master of Science at the State University of R'ew \'ark at Buffalo.
Carcinoma of the male breast is rare, representing 0.2 to 1.5%1.\* of all cancers in males; less than 1% of patients with cancer of the breast are males. In a recent review of carcinoma of the male breast by Crichlow, of 1158 reported cases only 16 (1.4%) were bilateral. Three of these were reported